Phytochemical Composition and Antipseudomonal Activity of Allanblackia gabonensis (Clusiaceae) Extracts Alone and With Antibiotics Against Drug‐Resistant Clinical Isolates
Open Access
- 2 March 2026
- journal article
- Vol. 2026, 6070077
Abstract
The discovery of alternative therapies for illnesses due to multidrug‐resistant (MDR) bacteria is emerging as a global health crisis. This study aimed to assess the antibacterial efficacy of Allanblackia gabonensis extracts, both alone and in conjunction with antibiotics, against MDR Pseudomonas aeruginosa. The extracts were subjected to phytochemical analysis using both qualitative and quantitative standard tests. The microdilution assay was used to evaluate the antibacterial properties and antibiotic resistance‐modifying potential of the extracts. The interaction effect between the antibiotics and extracts was determined by checkerboard assay. Catalase activity and lipid peroxidation were assessed by measuring the foam height and malondialdehyde concentration, respectively. The extracts exhibited minimum inhibitory concentrations (MICs) ranging from 16 to 2048 μg/mL. The hexane extracts of the leaves (HLE) and bark (HBE) displayed the highest antibacterial activity, with MIC ≤ 32 μg/mL against at least two investigated isolates. Furthermore, HLE decreased catalase activity and increased lipid peroxidation in P. aeruginosa D130. The extracts at their sub‐inhibitory concentration (MIC/8) enhanced the activity of antibiotics, mainly aminoglycosides (amikacin, streptomycin, and gentamicin), by 2‐ to 256‐fold against selected MDR P. aeruginosa. Among these extracts, the hexane and methanol bark extracts exhibited synergy (∑FIC ≤ 0.5)) in combination with these antibiotics. All examined extracts contained alkaloids, phenols, and triterpenes. Moreover, dichloromethane/methanol and methanol leaf extracts presented the highest phenolic content. Overall, the leaf and bark hexane extracts of A. gabonensis could serve as candidates for the discovery of new antibiotics, while its bark extracts might be used in conjunction with antibiotics to manage infections involving multidrug‐resistant P. aeruginosa.Keywords
This publication has 41 references indexed in Scilit:
- Natural Products As Sources of New Drugs over the 30 Years from 1981 to 2010Journal of Natural Products, 2012
- Analgesic and anti-inflammatory effect of aqueous extract of the stem bark of Allanblackia gabonensis (Guttiferae)Inflammopharmacology, 2011
- Activity and interactions of antibiotic and phytochemical combinations against Pseudomonas aeruginosa in vitroInternational Journal of Biological Sciences, 2010
- Antimicrobial activity of the crude extracts and compounds from Ficus chlamydocarpa and Ficus cordata (Moraceae)Journal of Ethnopharmacology, 2008
- Enhancement of the Antibiotic Activity against a Multiresistant Escherichia coli by Mentha arvensis L. and ChlorpromazineChemotherapy, 2008
- Pharmacodynamics of antimicrobial drugsInfectious Disease Clinics of North America, 2004
- Expression of the catalase gene katA in starter culture Lactobacillus plantarum TISTR850 tolerates oxidative stress and reduces lipid oxidation in fermented meat productInternational Journal of Food Microbiology, 2004
- Terminology relating to methods for the determination of susceptibility of bacteria to antimicrobial agentsClinical Microbiology and Infection, 2000
- Plant Products as Antimicrobial AgentsClinical Microbiology Reviews, 1999
- A Sensitive and Quick Microplate Method to Determine the Minimal Inhibitory Concentration of Plant Extracts for BacteriaPlanta Medica, 1998